The company aims to hire a researcher who will lead the project and a team to work with him, Spanish news website IDEA quoted the CEO Josep Escaich as saying.
The project will be developed as part of a cooperation agreement signed by Bioiberica with the healthcare council of the region of Andalusia last year.
Bioiberica will carry out the research at the clean room of the technology innovation complex CMAT in Granada.
The company is focused on the development of cell therapies for the prevention, diagnosis and treatment of osteoarthritis.
Medtronic seeks expanded US approvals for Hugo robotic surgery system
MiniMed expands Abbott partnership for dual glucose-ketone diabetes sensors
Lupin and Natco secure US FDA approval for generic Eribulin Mesylate Injection
Luminopia agrees international licensing deal for paediatric amblyopia treatment in Japan
FDA accepts Genentech's giredestrant application for early-stage breast cancer
Amgen receives EU marketing authorisation for IMDYLLTRA in ES-SCLC
Haisco receives US FDA approval for anaesthetic Cipepofol
Hanmi signs licensing deal with Lilly for sonefpeglutide
FDA approves TREMFYA label expansion
GSK reports positive phase III data for bepirovirsen in chronic hepatitis B
Sanofi's venglustat receives FDA priority review for type 3 Gaucher disease
CellCarta partners with Sonic Healthcare to commercialise companion diagnostics through Lab Network
Ribo submits Phase 2 trial application for RBD1119 to European regulator
US FDA extends review timeline for AstraZeneca's camizestrant application
Orsini to chosen as contracted specialty pharmacy for Gilead's Hepcludex (bulevirtide-gmod)